🟢 First Tracks Biotherapeutics is trading 5.6% up

First Tracks Biotherapeutics is trading at $33.46, up 5.62%, with no confirmed catalyst identified for the gain.

• No fresh company announcement dated October 14 was identified; the latest major news was positive ANB033 Phase 1b data announced October 12.
• The trial update does not establish the cause of this session’s gain. Biotech and major indexes were lower, offering no explanation for the rise.
• Shares fell 6.96% on October 13, but a rebound is not confirmed as the reason for the gain.